LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Biomanufacturing is vital to Europe’s future – EuropaBio’s Biomanufacturing Platform calls for ambition and action

30/05/2023

PRESS RELEASE

Brussels, 30 June 2023 – EuropaBio sets in stone the first European recommendations on biomanufacturing with the publication of its Biomanufacturing Policy Summit 2023 report. Following the recent launch of the EuropaBio Biomanufacturing Platform, the March Brussels Summit captured priorities of 80 industry leaders, policy makers and stakeholders to highlight the crucial role of cross-sectoral biomanufacturing for Europe's future.

EuropaBio Director-General Dr. Claire Skentelbery said “Biomanufacturing is a vital and significant part of Europe’s industrial future.  If Europe is to hit its ambitious targets in healthcare, sustainability, resilience and global competitiveness, biomanufacturing is an essential part of the mix. It is expanding in Europe but not is keeping pace with other global regions as they race to become global leaders in biomanufacturing. It is time for an ambitious cross-sectoral strategy and roadmap plus the policy and regulatory frameworks needed to ensure that Europe is a producer and not a customer”.

Recommendations advocate for a roadmap for Biomanufacturing, including recognition of biomanufacturing in the existing EU strategies, alignment across policy areas, targets for national biomanufacturing capacity and a global level playing field to enable and drive the scale up Europe’s industrial transition.

EuropaBio’s call to action emphasizes the need for ambitious measures and decisive steps to maximise the impact biomanufacturing, driving economic growth, addressing societal challenges, and advancing sustainable development goals.

Recommendations from the Summit will underpin EuropaBio’s growth of the Biomanufacturing Platform, working with industry across sectors to ensure that it receives the visibility and recognition required.

Biomanufacturing Policy Summit 2023 - Report & Recommendations


Download

Biomanufacturing is vital to Europe’s future – EuropaBio’s Biomanufacturing Platform calls for ambition and action


Download

Share
Alexandra Simionca
Alexandra Simionca

Related posts

26/06/2025

Health Biomanufacturing: Feedstock for Preparedness and Resilience


Read more
22/05/2025

Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World


Read more
19/03/2025

Measuring the Economic Footprint of the Biotechnology Industry in the European Union


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.